2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine

C119H129BrN28O30 — CID 161076877

IUPAC2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine
SMILESCC(C)(C)OC(=O)CBr.CCCOCCNC(=O)COc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O.Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)c([N+](=O)[O-])c1)nn2C1CCN(CC(=O)NCCOCCOCCOCCNC(=O)COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1.Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)c([N+](=O)[O-])c1)nn2C1CCN(CC(=O)O)CC1.Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)c([N+](=O)[O-])c1)nn2C1CCNCC1
InChIInChI=1S/C47H51N11O13.C24H23N7O5.C22H21N7O3.C20H23N3O7.C6H11BrO2/c48-43-41-42(29-9-11-35(34(25-29)58(65)66)71-31-5-2-1-3-6-31)54-57(44(41)52-28-51-43)30-13-17-55(18-14-30)26-38(60)49-15-19-67-21-23-69-24-22-68-20-16-50-39(61)27-70-36-8-4-7-32-40(36)47(64)56(46(32)63)33-10-12-37(59)53-45(33)62;25-23-21-22(15-6-7-19(18(12-15)31(34)35)36-17-4-2-1-3-5-17)28-30(24(21)27-14-26-23)16-8-10-29(11-9-16)13-20(32)33;23-21-19-20(27-28(22(19)26-13-25-21)15-8-10-24-11-9-15)14-6-7-18(17(12-14)29(30)31)32-16-4-2-1-3-5-16;1-2-9-29-10-8-21-16(25)11-30-14-5-3-4-12-17(14)20(28)23(19(12)27)13-6-7-15(24)22-18(13)26;1-6(2,3)9-5(8)4-7/h1-9,11,25,28,30,33H,10,12-24,26-27H2,(H,49,60)(H,50,61)(H2,48,51,52)(H,53,59,62);1-7,12,14,16H,8-11,13H2,(H,32,33)(H2,25,26,27);1-7,12-13,15,24H,8-11H2,(H2,23,25,26);3-5,13H,2,6-11H2,1H3,(H,21,25)(H,22,24,26);4H2,1-3H3
InChIKeyUFJXVTVCCWVUGX-UHFFFAOYSA-N
MW2511.41 g/mol
LogP11.11
Rot. Bonds45

About 2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine

2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine (PubChem CID 161076877) has the molecular formula C119H129BrN28O30 and a molecular weight of 2511.41 g/mol. Its IUPAC name is 2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine.

Molecular Properties

Compound Name2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine
PubChem CID161076877
Molecular FormulaC119H129BrN28O30
Molecular Weight2511.41 g/mol
Exact Mass2508.86
IUPAC Name2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine
SMILESCC(C)(C)OC(=O)CBr.CCCOCCNC(=O)COc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O.Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)c([N+](=O)[O-])c1)nn2C1CCN(CC(=O)NCCOCCOCCOCCNC(=O)COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1.Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)c([N+](=O)[O-])c1)nn2C1CCN(CC(=O)O)CC1.Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)c([N+](=O)[O-])c1)nn2C1CCNCC1
InChIInChI=1S/C47H51N11O13.C24H23N7O5.C22H21N7O3.C20H23N3O7.C6H11BrO2/c48-43-41-42(29-9-11-35(34(25-29)58(65)66)71-31-5-2-1-3-6-31)54-57(44(41)52-28-51-43)30-13-17-55(18-14-30)26-38(60)49-15-19-67-21-23-69-24-22-68-20-16-50-39(61)27-70-36-8-4-7-32-40(36)47(64)56(46(32)63)33-10-12-37(59)53-45(33)62;25-23-21-22(15-6-7-19(18(12-15)31(34)35)36-17-4-2-1-3-5-17)28-30(24(21)27-14-26-23)16-8-10-29(11-9-16)13-20(32)33;23-21-19-20(27-28(22(19)26-13-25-21)15-8-10-24-11-9-15)14-6-7-18(17(12-14)29(30)31)32-16-4-2-1-3-5-16;1-2-9-29-10-8-21-16(25)11-30-14-5-3-4-12-17(14)20(28)23(19(12)27)13-6-7-15(24)22-18(13)26;1-6(2,3)9-5(8)4-7/h1-9,11,25,28,30,33H,10,12-24,26-27H2,(H,49,60)(H,50,61)(H2,48,51,52)(H,53,59,62);1-7,12,14,16H,8-11,13H2,(H,32,33)(H2,25,26,27);1-7,12-13,15,24H,8-11H2,(H2,23,25,26);3-5,13H,2,6-11H2,1H3,(H,21,25)(H,22,24,26);4H2,1-3H3
InChIKeyUFJXVTVCCWVUGX-UHFFFAOYSA-N
XLogP11.11
TPSA757.86 Ų
H-Bond Donors10
H-Bond Acceptors47
Rotatable Bonds45
Heavy Atoms178
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002511.41
LogP ≤ 511.11
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1047

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine?
The IUPAC name of 2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine (CID 161076877) is 2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine.
What is the SMILES notation for 2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine?
The canonical SMILES for 2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine is CC(C)(C)OC(=O)CBr.CCCOCCNC(=O)COc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O.Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)c([N+](=O)[O-])c1)nn2C1CCN(CC(=O)NCCOCCOCCOCCNC(=O)COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1.Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)c([N+](=O)[O-])c1)nn2C1CCN(CC(=O)O)CC1.Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)c([N+](=O)[O-])c1)nn2C1CCNCC1.
What is the InChIKey of 2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine?
The InChIKey is UFJXVTVCCWVUGX-UHFFFAOYSA-N. The full InChI is InChI=1S/C47H51N11O13.C24H23N7O5.C22H21N7O3.C20H23N3O7.C6H11BrO2/c48-43-41-42(29-9-11-35(34(25-29)58(65)66)71-31-5-2-1-3-6-31)54-57(44(41)52-28-51-43)30-13-17-55(18-14-30)26-38(60)49-15-19-67-21-23-69-24-22-68-20-16-50-39(61)27-70-36-8-4-7-32-40(36)47(64)56(46(32)63)33-10-12-37(59)53-45(33)62;25-23-21-22(15-6-7-19(18(12-15)31(34)35)36-17-4-2-1-3-5-17)28-30(24(21)27-14-26-23)16-8-10-29(11-9-16)13-20(32)33;23-21-19-20(27-28(22(19)26-13-25-21)15-8-10-24-11-9-15)14-6-7-18(17(12-14)29(30)31)32-16-4-2-1-3-5-16;1-2-9-29-10-8-21-16(25)11-30-14-5-3-4-12-17(14)20(28)23(19(12)27)13-6-7-15(24)22-18(13)26;1-6(2,3)9-5(8)4-7/h1-9,11,25,28,30,33H,10,12-24,26-27H2,(H,49,60)(H,50,61)(H2,48,51,52)(H,53,59,62);1-7,12,14,16H,8-11,13H2,(H,32,33)(H2,25,26,27);1-7,12-13,15,24H,8-11H2,(H2,23,25,26);3-5,13H,2,6-11H2,1H3,(H,21,25)(H,22,24,26);4H2,1-3H3.
What are the key properties of 2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine?
2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine has a molecular weight of 2511.41 g/mol, XLogP of 11.11, 45 rotatable bonds, 10 hydrogen bond donors, and 47 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]acetic acid;2-[4-[4-amino-3-(3-nitro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-N-[2-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethoxy]ethyl]acetamide;tert-butyl 2-bromoacetate;2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy-N-(2-propoxyethyl)acetamide;3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine is sourced from PubChem (CID 161076877), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).